Yale SOM’s Jeffrey Sonnenfeld, governance expert Nell Minow, and co-author Stephen Henriques argue that the proposed combination would illegally concentrate power in Hollywood, weaken labor markets, and carry mounting financial risks, even if it ultimately closes.

The FDA should recommit to transparent, evidence-based decision-making, apply its standards consistently, and modernize its regulatory systems, argue Yale SOM’s Jeffrey Sonnenfeld, Megan Ranney and Sten Vermund of the Yale School of Public Health, and Harvard neurologist Patricia Greenstein, with co-author Steven Tian.

The SpaceX IPO has renewed debate over dual-class share structures, which give founders outsized voting power. Yale SOM’s Jeffrey Sonnenfeld and co-author Steven Tian argue that these structures can create long-term shareholder value under the right conditions.

Yale SOM’s Jeffrey Sonnenfeld argues that the proliferation of organizations fighting for democracy has divided resources, muddled messaging, and discouraged potential allies.

Yale SOM’s Jeffrey Sonnenfeld and co-author Steven Tian argue that after falling short of his stated objectives in Iran, President Trump has turned to a familiar set of political and rhetorical tactics: declaring victory, redirecting public attention, and recasting friends as foes and foes as friends.

By striking down Trump’s tariff authority, write Yale SOM’s Jeffrey Sonnenfeld and co-author Steven Tian, the Supreme Court handed him a chance to retreat from a damaging trade war while claiming credit for a more effective negotiating strategy.

Yale SOM leadership expert Jeffrey Sonnenfeld and co-author Steven Tian argue that Apple is executing a model succession, with the transition from Tim Cook to John Ternus positioning the company to embed AI at scale across its global hardware ecosystem.

The president’s relentless self-branding is intended to signal success and sustain authority, Yale SOM’s Jeffrey Sonnenfeld and Steven Tian argue, but beneath the gold-plated surface lies a deeper fragility.